Alpha Cognition Launches ZUNVEYL, First Oral Alzheimer’s Drug Approved by FDA in a Decade
32-Person Sales Team Targets $2 Billion Long-Term Care Market as Company Marks Major Milestone in Alzheimer’s Treatment Alpha Cognition (ACOG) ...
Tag: ACOG
Alpha Cognition Secures $44 Million Licensing Deal with CMS for ZUNVEYL in Asia-Pacific
Agreement Paves the Way for Advanced Alzheimer’s Treatment in China and Beyond Alpha Cognition (ACOG), a biopharmaceutical company at the ...
